Citigroup’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.23M | Sell |
289,854
-87,425
| -23% | -$2.48M | ﹤0.01% | 1115 |
|
|
2025
Q1 | $11.1M | Buy |
377,279
+187,325
| +99% | +$5.53M | 0.01% | 938 |
|
|
2024
Q4 | $5.52M | Buy |
189,954
+78,272
| +70% | +$2.28M | ﹤0.01% | 1334 |
|
|
2024
Q3 | $5.13M | Buy |
111,682
+67,761
| +154% | +$3.11M | ﹤0.01% | 1321 |
|
|
2024
Q2 | $1.79M | Sell |
43,921
-191,944
| -81% | -$7.84M | ﹤0.01% | 1840 |
|
|
2024
Q1 | $6.02M | Buy |
235,865
+150,263
| +176% | +$3.83M | ﹤0.01% | 1146 |
|
|
2023
Q4 | $775K | Sell |
85,602
-56,926
| -40% | -$515K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $909K | Sell |
142,528
-36,204
| -20% | -$231K | ﹤0.01% | 1988 |
|
|
2023
Q2 | $1.98M | Sell |
178,732
-75,839
| -30% | -$841K | ﹤0.01% | 1698 |
|
|
2023
Q1 | $3.91M | Buy |
254,571
+139,726
| +122% | +$2.14M | ﹤0.01% | 1219 |
|
|
2022
Q4 | $2.55M | Buy |
114,845
+46,684
| +68% | +$1.04M | ﹤0.01% | 1364 |
|
|
2022
Q3 | $1.11M | Buy |
68,161
+11,916
| +21% | +$195K | ﹤0.01% | 2029 |
|
|
2022
Q2 | $817K | Buy |
56,245
+28,583
| +103% | +$415K | ﹤0.01% | 2238 |
|
|
2022
Q1 | $511K | Sell |
27,662
-46,079
| -62% | -$851K | ﹤0.01% | 2826 |
|
|
2021
Q4 | $1.75M | Buy |
73,741
+14,596
| +25% | +$347K | ﹤0.01% | 2075 |
|
|
2021
Q3 | $1.46M | Sell |
59,145
-45,482
| -43% | -$1.12M | ﹤0.01% | 2126 |
|
|
2021
Q2 | $2.59M | Buy |
104,627
+28,119
| +37% | +$695K | ﹤0.01% | 1911 |
|
|
2021
Q1 | $1.67M | Buy |
76,508
+71,383
| +1,393% | +$1.56M | ﹤0.01% | 2038 |
|
|
2020
Q4 | $131K | Buy |
5,125
+4,322
| +538% | +$110K | ﹤0.01% | 3503 |
|
|
2020
Q3 | $23K | Buy |
+803
| New | +$23K | ﹤0.01% | 3877 |
|